Holdings

台杉水牛二號生技創投有限合夥

As of Sep 30, 2026, 台杉水牛二號生技創投有限合夥 reported 2 positions. Largest: Annji Pharmaceutical Co., Ltd. and Elixiron Immunotherapeutics (cayman) Limited. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Annji Pharmaceutical Co., Ltd.15.5Mno changeSep 30, 2026
Elixiron Immunotherapeutics (cayman) Limited12M−784KSep 30, 2026